Physician

Rosie Qin Krypel, M.D.

According to 2025 Medicare claims, Rosie Krypel, M.D. (NPI: 1184087983) practices dermatology in the Yuba City, CA market, with the plurality of this provider's patient population coming from Sutter, CA. This provider's primary affiliated billing organization is SUTTER VALLEY MEDICAL FOUNDATION (NPI: 1992939565; TIN: 680273974) and primary practice location at 95991-4123. Krypel is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Krypel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,256 traditional Medicare patients, billed 9,478 HCPCS/CPT codes, and received $494,189 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,023 prescription claims across 437 beneficiaries totaling $553,478 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 3 records totaling $122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $2,027 to $553,478. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$247K$494K2021 Medicare payment: $72,189 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $257,218 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $455,947 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $494,189 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20212401,170$72,189
20228315,166$257,218
20231,1228,132$455,947
20241,2569,478$494,189

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$305K$610K2018 Drug cost: $2,027 (USD; Tot_Drug_Cst)2019 Drug cost: $7,534 (USD; Tot_Drug_Cst)2020 Drug cost: $857 (USD; Tot_Drug_Cst)2021 Drug cost: $207,898 (USD; Tot_Drug_Cst)2022 Drug cost: $189,810 (USD; Tot_Drug_Cst)2023 Drug cost: $610,265 (USD; Tot_Drug_Cst)2024 Drug cost: $553,478 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182049$2,027
201939114$7,534
2020N/R13$857
202170143$207,898
2022233594$189,810
2023388891$610,265
20244371,023$553,478

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more586956$91
11102Biopsy of related skin growth, first growth550724$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7321,076$64
17000Destruction of precancer skin growth, 1 growth7341,078$37
17003Destruction of precancer skin growth, 2-14 growths4992,521$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab391,078$137,567
Cosentyx Sensoready (2 Pens)Secukinumab14392$119,769
KetoconazoleKetoconazole2537,028$4,850
FluorouracilFluorouracil572,172$3,966
Clobetasol PropionateClobetasol Propionate741,804$2,358

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$122Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rosie Qin Krypel, M.D.?

Tedicare shows public-source Medicare data for Rosie Qin Krypel, M.D. (NPI 1184087983), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rosie Qin Krypel, M.D. have ACO affiliation data?

Rosie Qin Krypel, M.D. is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Rosie Qin Krypel, M.D.?

Rosie Qin Krypel, M.D. is linked to SUTTER VALLEY MEDICAL FOUNDATION (billing NPI 1992939565) in the available physician profile data.

Does Rosie Qin Krypel, M.D. have Open Payments data?

Rosie Qin Krypel, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.